Russian Scientists Say Sputnik Vaccine Vaccine Works Well Against New COVID-19 Variants

Last month, President Vladimir Putin ordered a review by March 15 of vaccines produced in Russia to determine their effectiveness against new variants that are spreading in different parts of the world. And now Russian scientists claim that injecting revaccination of Sputnik V to protect against newer variants of the coronavirus is producing strong results.

“(A) recent study conducted by the Gamaleya Center in Russia showed that revaccination with the Sputnik V vaccine works very well against new coronavirus mutations, including coronavirus strains from UK and South Africa, ”said Denis Logunov, deputy director of the center that developed the vaccination.

The results of the trial are expected to be released soon, but that was the first indication of how the testing is going. No further details are available yet.

So-called viral vector injections, like Sputnik V and a vaccine developed by AstraZeneca, use harmless modified viruses as vehicles or vectors to carry genetic information that helps the body build immunity against future infections.

The revaccination used the same injection of Sputnik V, based on the same adenovirus vectors. The trial indicated that it did not affect the effectivenessLogunov said in a statement to Reuters. Some scientists have raised the possible risk that the body will also develop immunity to the vector itself, recognizing it as an intruder and attempting to destroy it. But the developers of Sputnik V don’t think this poses any long-term problems. “We believe that vector-based vaccines are actually better for future revaccination than vaccines based on other platforms,” ​​Logunov said.

Sputnik light

The developers of the Russian vaccine Sputnik V yesterday applied for registration of the drug Sputnik Light, their single-dose vaccine against the coronavirus. As the producers reported on the drug’s official Twitter account, the immunizare “is released worldwide in March”.

Gamaleya director Alexandr Gintsburg explained that the safety of the single-dose vaccine is “proven”, but its effectiveness for use in the elderly remains to be investigated. In your opinion, Sputnik Light will be used to reduce mortality in situations where it is not possible to inoculate the two doses needed to strengthen immunity.

Vladimir Poutine, presented in mid-December during the annual press conference the “Sputnik Light”, of which he estimated the effectiveness at 85%.

The President of the Russian Direct Investment Fund (FIDR), Kiril Dmitriev, explained that Sputnik Light is intended for the foreign market and “may become a temporary and effective solution for many countries which are at the height of the disease and want to save as many lives as possible”.

“The first participants in the Sputnik Light vaccine research have already been vaccinated. As the volunteers pass the exams, the number of vaccinated will increase“Said the deputy mayor of Moscow yesterday, Anastasía Rákova, quoted by the Russian press agency Interfax. According to the official, there is currently a registration process for active volunteering, 490 of whom have had medical examinations in the past two days and were vaccinated this Saturday.

On February 18, the mayor of Moscow, Sergei Sobianin, announced that ten polyclinics in the capital would participate in this international phase, with a total of 6000 volunteers, 3000 from Moscow and the rest of the United Arab Emirates.

MORE ON THIS TOPIC: